Linking H1 with chromatin and growth control. by Munro, S, La Thangue, N

Cell cycle control by a methylation-phosphorylation switch. by Carr, S, La Thangue, N

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications. by Khan, O, La Thangue, N

Predictive biomarkers: A paradigm shift towards personalized cancer medicine by La Thangue, N, Kerr, D

Regulation of actin nucleation and autophagosome formation. by Coutts, A, La Thangue, N

Lysine methylation and the regulation of p53. by Carr, S, Munro, S, La Thangue, N

Strap: a versatile transcription co-factor. by Xu, D, La Thangue, N

Mdm2 widens its repertoire. by Coutts, A, La Thangue, N

T-ARG-eting E2F-1 growth control. by Moehlenbrink, J, La Thangue, N

Diversity within the pRb pathway: is there a code of conduct? by Munro, S, Carr, S, La Thangue, N

Predictive biomarkers: a paradigm shift towards personalized cancer medicine. by La Thangue, N, Kerr, D

Biomarkers for predicting clinical responses to HDAC inhibitors. by Stimson, L, La Thangue, N

Actin nucleation by WH2 domains at the autophagosome. by Coutts, A, La Thangue, N

Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas. by Khan, O, La Thangue, N

Pleiotropic effect of somatic mutations in the E2F subunit DP-1 gene in human cancer. by Munro, S, Oppermann, U, La Thangue, N

Functional interplay between E2F7 and ribosomal rRNA gene transcription regulates protein synthesis by Coutts, A, Munro, S, La Thangue, N

Pleiotropic effect of somatic mutations in the E2F subunit DP-1 gene in human cancer by Munro, S, Oppermann, U, La Thangue, N

Tumor classification for tailored cancer therapy by McLaughlin, F, LaThangue, N

p53 methylation--the Arg-ument is clear. by Durant, S, Cho, E, La Thangue, N

p53 ubiquitination by Mdm2: a never ending tail? by Coutts, A, Adams, C, La Thangue, N